Isbn: 9781835569870 - designing innovation around patient access and responsibility: why early decisions determine who gets treated (12 Ergebnisse)

Paperback or Softback. Zustand: New. Designing Innovation Around Patient Access and Responsibility: Why Early Decisions Determine Who Gets Treated. Book.

Zustand: New.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 355 pages. 6.00x0.80x9.00 inches. In Stock.

Paperback. Zustand: new. Paperback. Pharmaceutical innovation succeeds every day, yet patient access too often does not.Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Zustand: New. Print on Demand.

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceutical innovation succeeds every day, yet patient access too often does not.Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches.…

Paperback. Zustand: new. Paperback. Pharmaceutical innovation succeeds every day, yet patient access too often does not.Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. …

Taschenbuch. Zustand: Neu. Designing Innovation Around Patient Access and Responsibility | Why Early Decisions Determine Who Gets Treated | Tony Toks Akiwumi | Taschenbuch | Englisch | 2026 | Hmd Publishing | EAN 9781835569870 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…